Akers Biosciences, Inc. reported raising $18.1 Million in an initial SEC Form D filing, from an offering of $18.1 Million
PUBLIC · QCLSNov 24, 2020
Amount Raised
$18.1 Million
$18.1 Million sold, per SEC Form D (first sale Nov 24, 2020)
Round Type
Venture
ThorofareInformation TechnologyHealthcareSoftwareArtificial IntelligenceMachine LearningQuality AssuranceWho to call at Q/C Technologies, Inc., and when
A new round usually means Q/C Technologies, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Q/C Technologies, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Q/C Technologies, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Q/C Technologies, Inc.. With Fundz connected, it knows.
Watch Fundz in
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Q/C Technologies, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
1 contact
Q/C Technologies, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.